THOMAS E. GARDNER

THOMAS E. GARDNER

Tom Gardner is CEO and founder of Omeza, LLC. Tom is co-founder of KeyView Labs (cognitive health dietary supplements), former chairman of IntegriChain (informed software applications for the pharmaceutical industry sold to Accel-KKR), and former chairman of MMIT (managed market insights and technology for the pharmaceuticals industry). He is co-founder of BRIDGE Angel Investors, LLC.

Earlier, Tom was CEO of several public and private companies including Nucryst Pharmaceuticals (sold to Smith & Nephew), Songbird Hearing (sold controlling interest to Procter & Gamble), Datamonitor (IPO on London Stock Exchange), Base Ten Systems (assets sold to Smiths Aerospace and ABB Group), and Access Health (sold to HBOC and now part of McKesson Health Solutions). Earlier, Tom held marketing and general management positions at Procter & Gamble and Johnson & Johnson. He earned a B.A. in Economics and Mathematics from the University of St. Thomas (Minnesota) and has been a guest lecturer on marketing channels at Northwestern University’s Kellogg Graduate School of Management.